MedPath

PREVAIL-TA: Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe)

Not Applicable
Completed
Conditions
Aortic Valve Stenosis
Registration Number
NCT01238835
Lead Sponsor
Edwards Lifesciences
Brief Summary

A single arm, prospective multicenter non-randomized confirmatory clinical trial evaluating the Edwards SAPIEN XT™ transcatheter heart valve (model 9300TFX; "study valve"), the next generation Ascendra™ transapical delivery system, and crimper accessories.

Detailed Description

Purpose: The purpose of this trial is to evaluate the acute safety and effectiveness of the SAPIEN XT™ study valve and next generation Ascendra™ delivery components.

Follow-up Intervals: Subject data collection will include clinical information at baseline and during the index procedure. Subjects will undergo clinical follow-up at discharge, 30 days, 6 month annually for 5 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
220
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of Deaths30 days

Number of death at 30-days from the index procedure.

Secondary Outcome Measures
NameTimeMethod
Number of Participants With a Stroke30-days

Total Number of Participants with a Stroke.

Trial Locations

Locations (20)

Medizinische Universitat Wien Univ.Klinik f.Chirurgie

🇦🇹

Wien, Austria

Hôspital Bichat

🇫🇷

Paris, France

Herz-Und Gefasszentrum Bad Bevensen

🇩🇪

Bad Bevensen, Germany

Kerckhoff-Klinik

🇩🇪

Bad Nauheim, Germany

Herz-und-Gefass Klinik

🇩🇪

Bad Neustadt An Der Saale, Germany

Herz-und Diabeteszentrum NRW

🇩🇪

Bad Oeynhausen, Germany

Schüchtermann-Klinik

🇩🇪

Bad Rothenfelde, Germany

Heart Center University Cologne

🇩🇪

Cologne, Germany

Herzzentrum Dresden GmbH

🇩🇪

Dresden, Germany

University Clinic Erlangen

🇩🇪

Erlangen, Germany

Scroll for more (10 remaining)
Medizinische Universitat Wien Univ.Klinik f.Chirurgie
🇦🇹Wien, Austria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.